Community Benefits of Dual-Active-Ingredient Insecticidal Nets Against Malaria in Tanzania
Background
Long-lasting insecticidal nets (LLINs) were effective against malaria, but mosquitoes have become resistant to the main insecticides used. To address this, new dual-active ingredient LLINs (dual-AI LLINs) have been introduced. It’s essential to know how much these nets need to be used in a community to protect even those who don’t use them.
Methods
We analyzed data from a 3-year randomized controlled trial in 84 areas of North-western Tanzania. We tested three types of dual-AI LLINs against a standard LLIN. We checked malaria rates in children aged 6 months to 14 years across five surveys from 2020 to 2022.
Results
We tested 22,479 children from 12,654 households. When more than 40% of a community used dual-AI LLINs, non-users showed significant protection against malaria:
- Chlorfenapyr arm: 44% less likely to get malaria
- PBO arm: 55% less likely to get malaria
- Pyriproxyfen arm: 61% less likely to get malaria
Even when community usage was below 40% for the chlorfenapyr arm, non-users still had better protection than those in areas with high usage of standard LLINs.
Conclusion
Our study shows that when at least 40% of a community uses dual-AI LLINs, non-users also benefit. This highlights the importance of LLINs in protecting users and those around them from malaria.
Clinical Trials and Healthcare Solutions
Clinical trials are essential for developing safe and effective treatments. To ensure these benefits reach everyday medical practice, we introduce DocSym, an AI-driven platform that combines ICD-11 standards, clinical protocols, and research into one accessible resource for clinicians.
In today’s healthcare landscape, efficiency is vital. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, simplifying patient care management and expanding digital services.
By leveraging AI, clinics can improve workflows, enhance patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com.